AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
DAGENS INDUSTRI: Pharmacia sells Biovitrum for SKR 1.4 bn.
Biovitrum, which carries out Pharmacia's Swedish research into metabolic disorders, is to become independent.
Pharmacia will therefore have no basic research activities remaining in Sweden.
External investors, with Nordic Capital and MPM Capital at the helm, are buying two thirds of Biovitrum for SKR 1 bn.
The purchasers will inject SKR 800 M of capital into Biovitrum and will acquire shares from Pharmacia for SKR 200 M.
In addition, the consortium has undertaken to make a further SKR 400 M available to Biovitrum when it …
-
- Biovitrum AB interim report 1 Jan 2009 - 30 Sep 2009.
-
News wire article from: Chemical Business Newsbase
October 22, 2009
700+ words
-
- Dagens Industri: Biovitrum plans stock exchange flotation.
-
News wire article from: Asia Africa Intelligence Wire
October 2, 2002
700+ words
-
- Biovitrum - Interim report 1 Jan 30 Sep 2008.
-
News wire article from: Chemical Business Newsbase
October 22, 2008
700+ words
-
- Biovitrum AB full year report 2008.
-
News wire article from: Chemical Business Newsbase
February 10, 2009
700+ words
-
- Biovitrum and GlaxoSmithKline collaborate in antiobesity drug development.
-
News wire article from: Asia Africa Intelligence Wire
October 24, 2002
700+ words
